Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Quantitative and qualitative differences in protein expression between papillary thyroid carcinoma and normal thyroid

Lewis M Brown1, Steve M Helmke, Stephen W Hunsucker

  • 1Department of Pediatrics, Section of Pulmonary Medicine, The University of Colorado at Denver and Health Sciences Center, Aurora, 80045, USA.

Molecular Carcinogenesis
|June 22, 2006
PubMed
Summary

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Genetic drivers of etiologic heterogeneity in thyroid cancer.

Nature communications·2026
Same author

SMART Planning of Early-Stage Health Economic Decision Models for Mechanism-Based Precision Treatments in Rare Cancers: An Application and Tool Update.

PharmacoEconomics·2026
Same author

Light-Induced Proteomic Changes in Pseudomonas aeruginosa Biofilms.

Proteomics·2026
Same author

Targeting the Warburg Effect in Anaplastic Thyroid Carcinoma: Metabolic Vulnerabilities and Therapeutic Opportunities.

International journal of molecular sciences·2026
Same author

Author reply on: Prolactin-adjusted inferior petrosal sinus sampling: Pituitary and ectopic adrenocorticotropic hormone-dependent Cushing syndrome.

Journal of neuroendocrinology·2026
Same author

Clinical actionability of molecular testing in advanced thyroid cancer: a real-world cohort study.

European thyroid journal·2026

This study used proteomics to identify new biomarkers for papillary thyroid carcinoma (PTC). Researchers found significant protein differences between cancerous and normal thyroid tissue, identifying novel potential biomarkers like S100A6.

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Oncology

Background:

  • Papillary thyroid carcinoma (PTC) is the most common type of thyroid cancer.
  • Understanding the molecular mechanisms of PTC development is crucial for identifying new biomarkers.
  • Proteomic approaches offer a way to analyze global protein expression changes in cancer.

Purpose of the Study:

  • To identify differentially expressed proteins in papillary thyroid carcinoma (PTC) compared to normal thyroid tissue.
  • To discover novel protein biomarkers for PTC diagnosis and understanding its pathogenesis.
  • To investigate post-translational modifications and alternative splicing in PTC proteins.

Main Methods:

  • Difference gel electrophoresis (DIGE) was used to compare protein profiles of PTC and matched normal thyroid tissue.

Related Experiment Videos

  • Peptide mass fingerprinting (MALDI-TOFMS) and mass spectrometry were employed for protein identification.
  • Immunohistochemical analysis was performed to validate S100A6 as a potential biomarker.

    • Main Results:

    • Proteomic analysis revealed significant differential protein expression in PTC, with 35% of spots altered at a two-fold cutoff.
    • Ninety distinct proteins were identified, with 31 showing differential expression (excluding common proteins).
    • S100A6 was confirmed as a potential biomarker with 85% sensitivity and 69% specificity for distinguishing benign from malignant thyroid neoplasms.

    Conclusions:

    • Proteomic analysis using DIGE and mass spectrometry successfully identified known and novel potential biomarkers for PTC.
    • The study provides insights into the global pathophysiological changes occurring in PTC.
    • Novel biomarkers like S100A6 show promise for improved thyroid cancer diagnostics.